Sacubitril-Valsartan Does Not Impact Aortic Stiffness in HFrEF

WEDNESDAY, Sept. 4, 2019 -- For patients with heart failure and reduced ejection fraction (HFrEF), sacubitril-valsartan does not impact aortic stiffness versus enalapril but is associated with improvements in cardiac structure and function,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news